Pion

Billerica, United States Founded: 1996 • Age: 30 yrs Acquired By SFW Capital Partners
Company offering products and research services for determination of solubility, dissolution, permeability and human absorption

About Pion

Pion is a company based in Billerica (United States) founded in 1996 was acquired by SFW Capital Partners in May 2021. Pion offers products and services including Rainbow R6, SiriusT3, SCISSOR N3, Nano DeBEE Gen II, and PrepEngine. Pion operates in a competitive market with competitors including Cepheid, Beckman Coulter, Esco Lifesciences, Blackrock Neurotech and Fluidigm, among others.

Key Metrics

Products & Services of Pion

Pion offers a comprehensive portfolio of products and services, including Rainbow R6, SiriusT3, SCISSOR N3, Nano DeBEE Gen II, and PrepEngine.

Rainbow R6
Dissolution System

System for QC and R&D dissolution in drug testing.

SiriusT3
Compound Screening

Tool for screening pharmaceutical compounds effectively.

SCISSOR N3
Injection Simulator

Simulator for subcutaneous drug injection site testing.

Nano DeBEE Gen II
Homogenizer

Homogenizer for pharmaceutical processing applications.

PrepEngine
Laboratory Tech

Technology for laboratory preparation in drug development.

SDi2
Dissolution

Dissolution system for pharmaceutical analysis purposes.

PAMPA Kit
Permeability Testing

Kit for passive permeability testing in drugs.

Apps and channels of Pion

its YouTube channel Pion Inc. has 500 subscribers and 30 videos.

Pion Inc.
YouTube 500 subscribers 30 videos Science & Technology
Open channel

Videos from Pion

The most watched videos on Pion's YouTube channel, Pion Inc. (500 subscribers). Click a video to play it here.

Drug absorption, membrane permeability, flux, drug delivery and drug development
510 views
Unlocking Drug Efficiency | What is Intrinsic Dissolution Rate? (IDR)
496 views
Predictive Potential & Operational use of SCISSOR to streamline SC biologics drug development Merck
459 views
Drug Solubility and Permeability Basics | Drug absorption | BCS Drug Classes Explained
393 views

More on Pion Inc. .

Funding Insights of Pion

  • Total Rounds 3
  • Last Round Grant — $748,459
  • First Round $748,459

    (Aug 2005)

  • Investors Count 1

All 3 funding rounds of Pion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2009$748,459Grant––
Sep 2008$748,459Grant––
Aug 2005$748,459Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Pion

Pion has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and SFW Capital Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
SFW Capital Partners is focused on private equity investments in industrial and life sciences technology sectors.
2007sfwcap.comRye, United States
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for Pion

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Pion

10 people are tracked at Pion (4 in leadership, 6 in team).

NameRoleGroup
Tom Mohr
Chief Financial OfficerLeadership
Balint Sinko
Vp, Innovation And DevelopmentLeadership
Dan Klevisha
CEOLeadership
Alvin Rasmus
Chief Financial OfficerLeadership
Conor Gomes
Development ScientistTeam
Mark Bradshaw
Development EngineerTeam
Matthew Kilpeck
Lead Software EngineerTeam
Marisa Fraser - Moreira
Global Marketing Communications ManagerTeam
Darius Collard
Applications BiochemistTeam
Dr. Rebeca Ruiz
Principal ScientistTeam
Premium access

Complete people profiles for Pion

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Pion

4 dated milestones of Pion across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pion is founded.
  2. Funding First funding round of $748K.
  3. Funding Latest funding round, Grant, of $748K.
  4. Exit Acquired by SFW Capital Partners.

Competitors of Pion

Pion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Esco Lifesciences, Blackrock Neurotech and Fluidigm, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cepheid.com1996Sunnyvale, United States$19.1M1,299
Developer of molecular diagnostic testing solutions
beckman.com1935Brea, United States––
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
escolifesciences.com1978Singapore$400M–
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
blackrockneurotech.com2008Salt Lake, United States$22.37M127
Medical devices for neurological therapies are developed.
fluidigm.com1999San Francisco, United States$40.53M205
Instruments for life sciences research and applications are developed.
waters.com1958Milford, United States–9,341
Provider of laboratory management system for researchers and clinicians
bruker.com1960United States–9,707
Diversified research instrument systems are manufactured and supplied.
sartorius.com1870Gottingen, Germany–566
Laboratory and biopharmaceutical equipment is developed for production processes.
unchainedlabs.com2015Pleasanton, United States$111M–
Multiplex protein stability platform for biologics is developed.
Premium access

Detailed competitors of Pion

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Pion

The website of Pion (pion-inc.com) receives about 18.8K visits a month.

  • Monthly visits
    18.8K

    ▼ 17.5% vs previous month

Similar websites

Websites whose visitors overlap most with Pion. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
drawellanalytical.com
drawellanalytical.com
100%
–#450,462–
agriculture.institute
agriculture.institute
79%
–#324,319–
proteomefactory.com
proteomefactory.com
77%
–––
proteomeconsult.com
proteomeconsult.com
77%
–––
labmanager.com
labmanager.com
60%
–#273,992–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 6 similar websites and full traffic analytics for Pion

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Pion

Premium access

Complete news archive for Pion

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Pion

10 companies that operate in the same segment as Pion (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pion

Pion was founded in 1996 and raised its 1st funding round 9 years after it was founded.

Pion is headquartered in Billerica, United States. It is registered at Billerica, Massachusetts, United States.

Founded in 1996 and based in Billerica, United States, Pion operates in the pharmaceutical analytical sector. Contract services are provided for solubility, dissolution, permeability, ionization, lipophilicity, and compound profiling assessments. Formulation development is also supported. Key products include µSOL Evolution for solubility measurement, PAMPA for passive permeability evaluation, and µFLUX for dissolution and permeation analysis to inform pharmacokinetic decisions.

Pion's top competitors include Cepheid, Blackrock Neurotech and Esco Lifesciences.

Pion offers Rainbow R6, SiriusT3, SCISSOR N3, Nano DeBEE Gen II, and 3 more products and services.

Pion has 2 investors. Key investors include HHS, and SFW Capital Partners.

Pion operates through Pion Instruments, Inc..

Yes. Pion was acquired by SFW Capital Partners in May 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available